Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing ...

"These mechanisms collectively may reduce the risk of cognitive decline, particularly in diabetic patients, and warrant ...

A study reveals SGLT-2 inhibitors significantly reduce dementia risk in type 2 diabetes patients, with effects strengthening ...

By inhibiting SGLT-2 protein, these drugs enhance glucose excretion in urine, reducing blood glucose levels. This mechanism ...

The findings support the hypothesis that SGLT-2 inhibitors might influence dementia risk through mechanisms beyond glucose control, possibly involving direct neuroprotective effects or improved ...

The use of SGLT2 inhibitors was associated with a lower risk for recurrent ischemic stroke and all-cause mortality among patients with type 2 diabetes. The use of sodium-glucose co-transporter-2 ...

TUESDAY, Sept. 3, 2024 (HealthDay News) — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in ...